Monday June 24, 2019

Study: Plant-based Diets Can Help Diabetes Patients

According to the researchers, those with diabetes are two to four times more likely to die from cardiovascular disease than those who do not have diabetes

0
//
They found that specific risk factors varied from about a 2 per cent reduction (for blood pressure) to a 32 per cent reduction (for inflammation).
They found that specific risk factors varied from about a 2 per cent reduction (for blood pressure) to a 32 per cent reduction (for inflammation). Pixabay

Plant-based diets can be beneficial for diabetes as a new study has found that it may improve glycemic control, cholesterol and lead to weight loss in people with Type 2 diabetes.

The researchers suggest that plant-based diets benefit both glycemic control and cardiovascular health because they are low in saturated fat, rich in phytochemicals, high in fibre and often rich in low-glycemic fruits and vegetables.

“The link between diabetes and cardiovascular disease is strong. 60-70 per cent of people who have Type 2 diabetes die of heart disease,” said co-author Hana Kahleova, Director of Clinical Research at the Physicians Committee for Responsible Medicine in Washington DC.

“The good news is that this study shows that the same simple prescription — eating a plant-based diet — can reduce our risk for heart problems and improve Type 2 diabetes at the same time,” Kahleova added.

Representational image.
Representational image. Pixabay

According to the researchers, those with diabetes are two to four times more likely to die from cardiovascular disease than those who do not have diabetes.

For the study, published in the journal Clinical Nutrition, the researchers reviewed nine randomised controlled trials — nearly 700 participants — that assessed the effectiveness of vegan and vegetarian diets for diabetes patients.

Also Read: Study: Diabetes Treatment Gets Boost From ‘Surgery in a Pill’

The results suggested that those who ate a plant-based diet lowered their cholesterol, lost weight, lowered HbA1c levels, and improved other cardiometabolic risk factors when compared to those who ate a non-vegetarian diet.

There was no significant effect on fasting insulin, HDL-C, triglycerides or blood pressure. The overall certainty of evidence was moderate but was low for fasting insulin, triglycerides, and waist circumference. (IANS)

Next Story

Researchers Find Drug to Delay Type-1 Diabetes by Two Years

The effects of the drug were greatest in the first year after it was given, said the study published online in The New England Journal of Medicine

0
Diabetes
Representational image. Pixabay

In a first, researchers have found that a treatment affecting the immune system effectively slowed the progression to clinical Type-1 diabetes in high risk individuals by two years or more.

“The results have important implications for people, particularly youth, who have relatives with the disease, as these individuals may be at high risk and benefit from early screening and treatment,” said Lisa Spain, Project Scientist from US National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

The study, involving treatment with an anti-CD3 monoclonal antibody (teplizumab), was conducted by Type 1 Diabetes TrialNet, an international collaboration aimed at discovering ways to delay or prevent Type-1 diabetes.

Participants were randomly assigned to either the treatment group, which received a 14-day course of teplizumab, or the control group, which received a placebo.

All participants received glucose tolerance tests regularly until the study was completed, or until they developed clinical Type-1 diabetes – whichever came first.

During the trial, 72 per cent of the people in the control group developed clinical diabetes, compared to only 43 per cent of the teplizumab group.

diabetes
“Although Type-1 and Type-2 diabetes in parents are well-established risk factors for diabetes, we show that gestational diabetes mellitus may be a risk indicator for diabetes in the mother’s children before age 22,” . Pixabay

The median time for people in the control group to develop clinical diabetes was just over 24 months, while those who developed clinical diabetes in the treatment group had a median time of 48 months before progressing to diagnosis.

“The difference in outcomes was striking. This discovery is the first evidence we’ve seen that clinical Type-1 diabetes can be delayed with early preventive treatment,” Spain added.

Type-1 diabetes develops when the immune system’s T cells mistakenly destroy the body’s own insulin-producing beta cells.

Also Read- Cutting Sodium Intake May Prevent 94 Million Premature Deaths From CVD

Insulin is needed to convert glucose into energy. Teplizumab targets T cells to lessen the destruction of beta cells.

The effects of the drug were greatest in the first year after it was given, said the study published online in The New England Journal of Medicine. (IANS)